References
- Lu C-W, Wu M-H, Chen H-C, Kao F-Y, Huang S-K. Epidemiological profile of Wolff–Parkinson–White syndrome in a general population younger than 50years of age in an era of radiofrequency catheter ablation. Int J Cardiol. 2014;174(3):530–534. doi:10.1016/j.ijcard.2014.04.13424798784
- Blomström-Lundqvist C, Scheinman MM, Aliot EM, et al. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias—executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients with Supraventricular Arrhythmias) developed in collaboration with NASPE-Heart Rhythm Society. J Am Coll Cardiol. 2003;42:1493–1531. doi:10.1016/j.jacc.2003.08.01314563598
- Siegel SW, Moeller SE. Sacral neuromodulation for the treatment of overactive bladder (OAB) In: Raz S, Rodriquez L, editors. Female Urology. Philadelphia: WB Saunders Company; 2008:266–276.
- Ghazi AA, Elterman DS, Hassouna M. Sacral neuromodulation in patients with a cardiac pacemaker. Int Neurourol J. 2016;20:270–272. doi:10.5213/inj.1632536.26827706012
- Jonas U, Fowler CJ, Chancellor MB, et al. Efficacy of sacral nerve stimulation for urinary retention: results 18 months after implantation. J Urol. 2001;165:15–19. doi:10.1097/00005392-200101000-0000411125353
- Wallace PA, Lane FL, Noblett KL. Sacral nerve neuromodulation in patients with cardiac pacemakers. Am J Obstet Gynecol. 2007;197:94–e13. doi:10.1016/j.ajog.2007.04.01717618774